Checkmate Pharmaceuticals, Inc.·4

Mar 2, 4:10 PM ET

BASH ALAN 4

4 · Checkmate Pharmaceuticals, Inc. · Filed Mar 2, 2022

Insider Transaction Report

Form 4
Period: 2022-03-01
BASH ALAN
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-03-01+575,000575,000 total
    Exercise: $2.99Exp: 2032-03-01Common Stock (575,000 underlying)
Footnotes (1)
  • [F1]This stock option shall vest 25% on the first anniversary of the grant date and in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continued service through such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION